bioRxiv Science⌕ Search

Biology subjects

Dill, V.

Publications and source records attributed to Dill, V..

3 recordsLinked to original sources

The Effects of Intraspecies and Interspecies Competition on Genetic Device Construction and Performance

Future genetic devices expressed in microbes need to be tested in complex environments containing multiple organisms to expand their usability. We sought to determine if genetic parts designed for monoculture are predictable when used in co-culture by testing constitutive Anderson promoters driving expression of chromoproteins from a plasmid. In Escherichia coli monoculture a high copy number origin of replication causes stochastic expression regardless of promoter strength, and high Anderson promoter strength leads to selection for inactivating mutations, resulting in inconsistent chromoprotein expression. Medium and low strength Anderson promoters function more predictably in E. coli monoculture but experience an increase in inactivating mutations when grown in co-culture over many generations with Pseudomonas aeruginosa. Expression from native promoters instead of Anderson promoters can lead to stable expression in a complex wastewater culture. Overall, we show intraspecies selection for inactivating mutations due to a competitive growth advantage for E. coli that do not express the genetic device compared to their peers that retain the functional device. We show additional interspecies selection against the functional device when E. coli is co-cultured with another organism. Together, these two selection pressures create a significant barrier to genetic device function in microbial communities that we overcome by utilize a native E. coli promoter. Future strategies for genetic device design in microorganisms that need to function in a complex microbial environment should focus on native promoters and/or strategies that give the microorganism carrying the device a selective or growth advantage. ImportanceFirst generation biotechnology focused on genetic devices designed for use in monoculture conditions. Next generation biotechnology devices will need to function in complex ecosystems with other organisms, so we sought to create conditions where the genetic device retained function when the organism carrying it is in co-culture with other organisms. We discovered that when the genetic device is a significant resource burden on the organism carrying the device mutations will be selected for due to intraspecies and interspecies selection pressures and the device will be rendered non-functional. Therefore, genetic device design for complex ecosystems in next generation biotechnology needs to balance functionality of the genetic device with the need to reduce resource burden on the organism carrying it.

synthetic biology↗

Adherent and suspension baby hamster kidney cells have a different cytoskeleton and surface receptor repertoire

Animal cell culture, with single cells growing in suspension, ideally in a chemically defined environment, is a mainstay of biopharmaceutical production. The synthetic environment lacks exogenous growth factors and usually requires a time-consuming adaptation process to select cell clones that proliferate in suspension to high cell numbers. The molecular mechanisms that facilitate the adaptation and that take place inside the cell are largely unknown. Especially for cell lines that are used for virus antigen production such as baby hamster kidney (BHK) cells, the restriction of virus growth through the evolution of undesired cell characteristics is highly unwanted. The comparison between adherently growing BHK cells and suspension cells with different susceptibility to foot-and-mouth disease virus revealed differences in the expression of cellular receptors such as integrins and heparan sulfates, and in the organization of the actin cytoskeleton. Transcriptome analyses and growth kinetics demonstrated the diversity of BHK cell clones and confirmed the importance of well-characterized parental cell clones and mindful screening to make sure that essential cellular features do not get lost during adaptation.

cell biology↗

In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets

High-throughput sequencing describes multiple alterations in each tumor (1), but their functional relevance is often unclear. Clinic-close, individualized molecular model systems are required for functional validation and to identify therapeutic targets of high significance for each patient (2). Here, we established a Cre-ERT2-loxP based inducible RNAi-mediated gene silencing system in patient-derived xenograft (PDX) models of acute leukemias in vivo. Mimicking anti-cancer therapy in patients, gene inhibition was initiated in mice harboring orthotopic tumors. Fluorochrome guided, competitive in vivo trials identified a major tumor-maintaining potency of the MLL-AF4 fusion protein and validated MCL1 as vulnerability in some, but not all patients tumors. We could prove DUX4 to play an essential role in patients leukemias carrying the recently described DUX4-IGH translocation. By individualizing functional genomics in established tumors in vivo, our technique decisively complements the value chain of precision oncology. Being broadly applicable to tumors of all kinds, it will considerably reinforce personalizing anti-cancer treatment in the future.

cancer biology↗